Cancer.Net Associate Editor: Leukemia
Karmanos Cancer Institute
Charles Schiffer, MD, is a Professor of Medicine and Oncology at Wayne State University School of Medicine and the Karmanos Cancer Institute in Detroit, Michigan, and Director of the Leukemia/Lymphoma Multidisciplinary Program. His research interests focus on chemotherapy resistance, the therapy and biology of leukemia and other blood disorders, and platelet transfusion supportive care.
Dr. Schiffer has authored and co-authored more than 300 articles and 75 book chapters on topics concerning the treatment of leukemia in adults, platelet transfusion, and granulocyte transfusion therapy, among other topics. He has served on the editorial boards for Blood, the Journal of Clinical Oncology, International Journal of Hematology, Transfusion Medicine Reviews, and Transfusion. He also reviews articles for multiple journals. Committee memberships have included chairman of the Leukemia Committee of the Cancer and Leukemia Group B, chairman of the Food and Drug Administration Oncologic Drug Advisory Committee, and grant reviews for the National Cancer Institute and Leukemia/Lymphoma Society of America. In 2006, he received the Dr. John J. Kenney Award from the Leukemia/Lymphoma Society of America and the Celgene Award for Career Achievement in Hematology. He was recently inducted into the Academy of Scholars of Wayne State University. Dr. Schiffer has been named among Castle Connelly's “Best Doctors in America.”
Disclosure: In the past two years, Dr. Schiffer has received honoraria from Bristol-Myers Squibb and Novartis; served as a consultant/advisor to Wyeth, Novartis, Bristol-Myers Squibb, Amgen, Ariad, Pfizer, Celgene, and Ambit; and received research funding from Bristol-Myers Squibb, Novartis, Ariad, and Celgene.
Last Updated: November 07, 2011